Neumora Therapeutics, Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q3 2022 to Q3 2024

Taxonomy & unit: us-gaap: USD/shares
Description: The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary: Neumora Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q3 2022 to Q3 2024.
Neumora Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.45 USD/shares, a 60.5% increase year-over-year.
Neumora Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -1.15 USD/shares.
Neumora Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -3.63 USD/shares, a 24.5% increase from 2022.

Earnings Per Share, Basic, Trailing 12 Months (USD/shares)

Earnings Per Share, Basic, Quarterly (USD/shares)

Earnings Per Share, Basic, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	-$1	$0	+$0.69	+60.5%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-12
Q2 2024	-$2	$0	+$0.91	+71.1%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-06
Q1 2024	-$3	$0	+$0.88	+72.1%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-07
Q4 2023	-$4	$0.01			Oct 1, 2023	Dec 31, 2023	10-K	2024-03-07
Q3 2023		-$1	$0	-7.55%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-12
Q2 2023		-$1			Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-06
Q1 2023		-$1			Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-07
Q3 2022		-$1			Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-01

* An asterisk sign (*) next to the value indicates that the value is likely invalid.